课题基金 / 基金详情

Study on the establishment of a therapeutic system for severe cardiac failure by means of artificial heart as a bridge to heart transplantation

Study on the establishment of a therapeutic system for severe cardiac failure by means of artificial heart as a bridge to heart transplantation
以人工心脏为桥梁的心脏移植建立重症心力衰竭治疗体系的研究
批准号:
03454338
负责人:
SHIMIZU Takeshi
金额:
$3.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993

项目摘要

项目成果

SHIMIZU Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Left ventricular assist device composed of electrohydraulic linear actuator and diaphram type blood pump has been investigated in this institute together with Aisin Seiki LTD.In this study series, the control system of this VAD was designed and examined. From the pressure volume curve obtained in the blood pump Ea/Ees was calculated. It was possible to get Ea/Ees as near to 1 as possible by controling stroke volume, rate, upper duty, lower duty and % systole of the VAD using multiple regression analysis in this control system.2. In order to speculate the effect of coagulation and fibrinolysis during artificial circulation including VAD on the implanted donor heart and recipient, changes of coagulation and fibrinolysis were examined during and after Cardiopulmonary bypass(CPB) : thrombocytes, beta-TG, ATIII, FPA, PLG, D-dimer, alpha_2PI etc. Both coagulation and fibrinolysis were activated during CPB.Nafamostat Mesilate(NM), however, inhibited these activities. It is considered that … More NM administration might prevent thromboembolic and hemorrhagic episodes during ventricular assist.3. In order to study whether cell mediated immunity responses would be suppressed or activated by the effect of CPB or ventricular assist, peripheral blood lymphocyte subsets and antibody dependent cell mediated cytotoxicity were investigated during artificial circulation. The total lymmphocyte (OKT 3 and OKT 11+) number did not change significantly. Suppressor/cytotoxic T cell(OKT8+) and NK cell (Leu 7+ and Leu 11+) numbers remarkably increased. But helper/inducer T cell(OKT 4+) and B cell(Leu 12+) numbers decreased. Mixed lymphocyte reaction and NK cytotoxicity were also activated during this study. It may be concluded that open heart surgery using CPB is associated with the activation of cytotoxic cell mediated immunity.4. Inthe recipient of heart transplanation who undergoes VAD as a bridge, blood coagulation, fibrinolysis and cytotoxic cell mediated immunity would be activated and therefore the incidence of thromboembolic episode and acute rejection might increase compared with simple heart transplantation. Less
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
笹木 秀幹,清水 健: "開心術後の補助人工心臓の適用に関する実験的検討" 人工臓幹. 20. 732-735 (1991)
Hideki Sasaki、Ken Shimizu:“心脏直视手术后心室辅助装置应用的实验研究”Artificial Artificial Heart (人工心脏) 20. 732-735 (1991)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
笹木 秀幹: "Left ventricular pressure volume relationships in brain bead canine hearts ーpreoperative evaluation of donor heartsーpreoperative evaluation of donor hearts" Transplantation Proceedings. 2570-2572 (1989)
Hideki Sasaki:“脑珠犬心脏的左心室压力容积关系 - 供体心脏的术前评估 - 供体心脏的术前评估”移植论文集 2570-2572 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
藤田 毅,人見 滋樹,清水 健他: "心臓移植、肺移植" 日本胸部外科学会,臓器移植問題特別委員会 (株)金芳堂, 189 (1991)
Takeshi Fujita、Shigeki Hitomi、Ken Shimizu 等:“心脏移植、肺移植” 日本胸外科学会器官移植问题特别委员会,Konpodo Co., Ltd.,189(1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidemiki Sasaki, Takeshi Shimizu: "Experimental study on indication of ventricular assist device after open heart surgery." Artificial Organs. 20. 732-735 (1991)
Hidemiki Sasaki、Takeshi Shimizu:“心脏直视手术后心室辅助装置适应症的实验研究”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
38
    Effects of excercise continuity using motion games for groups who don't have exercise habits
    • 批准号:
      25750344
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.5万
    • 财政年份:
      2013
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位:
    Molecular mechanisms that function in oligodendrocyte myelination
    Study of Shiga toxin productions us ing in vivo analysis
    • 批准号:
      21590478
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位:
    Role of lipoxin as an inhibitory mediator in upper airway inflammation
    • 批准号:
      20591999
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      SHIMIZU Takeshi
    • 依托单位:
    海外基金